Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Maureen Achebe"'
Autor:
Biree Andemariam, Modupe Idowu, Nirmish Shah, Richard Drachtman, Archana Sharma, Alexander Glaros, Maureen Achebe, Alecia Nero, Brooke Hayward, Michelle Xu, Susanna Curtis
Publikováno v:
HemaSphere, Vol 7, p e139426f (2023)
Externí odkaz:
https://doaj.org/article/a657dd6d2aee4ef1885c26be62ee3e52
Autor:
Joshua J. Field, Elaine Majerus, Victor R. Gordeuk, Michel Gowhari, Carolyn Hoppe, Matthew M. Heeney, Maureen Achebe, Alex George, Hillary Chu, Brian Sheehan, Maneka Puligandla, Donna Neuberg, Gene Lin, Joel Linden, David G. Nathan
Publikováno v:
Blood Advances, Vol 1, Iss 20, Pp 1645-1649 (2017)
Abstract: Adenosine A2A receptor (A2AR) agonists have been shown to decrease tissue inflammation induced by hypoxia/reoxygenation in mice with sickle cell disease (SCD). The key mediator of the A2AR agonist's anti-inflammatory effects is a minor lymp
Externí odkaz:
https://doaj.org/article/942357e4a17d49cc81c39faf31825a81
Autor:
Miriam A. Osei, Lauren E. Merz, Siyang Ren, Donna S. Neuberg, Maureen Achebe, Jorge A. Rodriguez, Arielle L. Langer
Publikováno v:
Telemedicine journal and e-health : the official journal of the American Telemedicine Association.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e859acf64517839eebe4422f59bc3d57
https://pubmed.ncbi.nlm.nih.gov/36607804
https://pubmed.ncbi.nlm.nih.gov/36607804
Autor:
Maureen Achebe, Sarah Gray, Kenneth I. Ataga, Hoda Hassab, Amal El-Beshlawy, Elliott Vichinsky, Margaret Tonda, Videlis Nduba, Irene Agodoa, Jo Howard, Robert Clark Brown, Joshua Lehrer-Graiwer
Publikováno v:
The Lancet Haematology. 8:e323-e333
For decades, patients with sickle cell disease have had only a limited number of therapies available. In 2019, voxelotor (1500 mg), an oral once-daily sickle haemoglobin polymerisation inhibitor, was approved in the USA for the treatment of sickle ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f9f65fcf8ec26745fd1e15dc57df93b
https://doi.org/10.1016/s2352-3026(21)00059-4
https://doi.org/10.1016/s2352-3026(21)00059-4
Autor:
Mufaddal Mahesri, Sebastian Schneeweiss, Denise Globe, Alex Mutebi, Rhonda Bohn, Maureen Achebe, Raisa Levin, Rishi J. Desai
Publikováno v:
European Journal of Haematology. 106:273-280
Objectives Bone marrow transplantation (BMT) is currently the only curative therapy available for patients with sickle cell disease (SCD), but clinical outcomes in routine care are not well understood. We describe the rates of vaso-occlusive crises (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba6b725b62e5656db150ef6f9409fca3
https://doi.org/10.1111/ejh.13546
https://doi.org/10.1111/ejh.13546
Autor:
Thomas G. DeLoughery, Maureen Achebe
Publikováno v:
Transfusion
Background Reluctance to use intravenous (IV) iron for the treatment of iron deficiency continues due to a perceived high risk of severe hypersensitivity reactions (HSRs). Additionally, it has been hypothesized that 'dextran-derived' IV iron products
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80ed22ff595c36ec906639000a477416
http://europepmc.org/articles/PMC7384172
http://europepmc.org/articles/PMC7384172
Publikováno v:
The Hematologist. 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3dd72415a34f2e3b0af5d138e558b624
https://doi.org/10.1182/hem.v19.4.2022416
https://doi.org/10.1182/hem.v19.4.2022416
Autor:
Kabir O. Olaniran, Maureen Achebe, Sagar U. Nigwekar, Sophia H. Zhao, Ravi Thadhani, Andrew S. Allegretti, Sahir Kalim, Nwamaka D. Eneanya
Publikováno v:
J Am Soc Nephrol
BACKGROUND Sickle cell trait and sickle cell disease are thought to be independent risk factors for CKD, but the trajectory and predictors of kidney function decline in patients with these phenotypes are not well understood. METHODS Our multicenter,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c0300b575fb7b2e5f7ac33cccae755
https://doi.org/10.1681/asn.2019050502
https://doi.org/10.1681/asn.2019050502
Autor:
Brandon M. Hardesty, Modupe Idowu, Geetha Puthenveetil, Sharada A. Sarnaik, Abdullah Kutlar, Natasha M. Archer, Vince D. Cataldo, Shelley E. Crary, Brigid Scullin, Walter K. Kraft, Darla K. Liles, Victor R. Gordeuk, Wally R. Smith, Nirmish Shah, Kathryn L. Hassell, Maureen Achebe, Alan Ikeda, Julie Kanter, Payal C. Desai, Ralph V. Boccia
Publikováno v:
British journal of haematologyReferences. 195(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd5bb72d634be05f9b13d1dd416f5420
https://pubmed.ncbi.nlm.nih.gov/34611900
https://pubmed.ncbi.nlm.nih.gov/34611900
Autor:
Kabir O. Olaniran, Maureen Achebe, Sagar U. Nigwekar, Amita Sharma, Xavier F Vela-Parada, Ravi Thadhani, Nwamaka D. Eneanya
Publikováno v:
Blood Purification. 47:205-213
Background: Compared to the past, patients with sickle cell disease (SCD) currently live longer due to improvements in diagnosis and comprehensive care. Due to these advances, long-term chronic complications pose a greater challenge in the management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b45851c4078c77e17a55d4f9b407f81e
https://doi.org/10.1159/000494581
https://doi.org/10.1159/000494581